These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1066150

  • 1. Remission maintenance therapy for meningeal leukaemia: intrathecal methotrexate and dexamethasone versus intrathecal craniospinal irradiation with a radiocolloid.
    Muriel FS, Schere D, Barengols A, Eppinger-Helft M, Braier JL, Pavlovsky S, Macchi GH, Guman L.
    Br J Haematol; 1976 Sep; 34(1):119-27. PubMed ID: 1066150
    [Abstract] [Full Text] [Related]

  • 2. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia.
    Muriel FS, Svarch E, Pavlovsky S, Eppinger-Helft M, Braier J, Vergara B, Garay G, Kvicala R, Divito JM, Failace R, Dibar E, Jimenez E.
    Blood; 1983 Aug; 62(2):241-50. PubMed ID: 6575836
    [Abstract] [Full Text] [Related]

  • 3. Prevention of meningeal leukaemia and relapses by cranial irradiation and intrathecal MTX in acute lymphatic leukaemia.
    Krepler P, Kummer M, Pawlowsky J, Jentzsch K.
    Acta Neuropathol Suppl; 1975 Aug; Suppl 6():241-5. PubMed ID: 1057842
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of acute lymphoblastic leukaemia: effect of "prophylactic" therapy against central nervous system leukaemia. Report ot the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
    Br Med J; 1973 May 19; 2(5863):381-4. PubMed ID: 4574042
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
    Wahidijat I, Markum AH, Abdulsalam M, Muslichan S, Odang O.
    Acta Haematol; 1972 May 19; 47(2):81-8. PubMed ID: 4623363
    [No Abstract] [Full Text] [Related]

  • 7. Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia.
    Sullivan MP, Humphrey GB, Vietti TJ, Haggard ME, Lee E.
    Cancer; 1975 Apr 19; 35(4):1066-73. PubMed ID: 803866
    [Abstract] [Full Text] [Related]

  • 8. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME, Sather H, Robison LL, Donaldson M, Littman P, Ortega JA, Hammond GD.
    Cancer Res; 1982 Feb 19; 42(2):674-80. PubMed ID: 7034927
    [Abstract] [Full Text] [Related]

  • 9. IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia.
    Zeulzer WW, Ravindranath Y, Lusher JM, Sarnaik S, Considine B.
    Am J Hematol; 1976 Feb 19; 1(2):191-9. PubMed ID: 1069474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
    Kun LE, Camitta BM, Mulhern RK, Lauer SJ, Kline RW, Casper JT, Kamen BA, Kaplan BM, Barber SW.
    J Clin Oncol; 1984 May 19; 2(5):359-64. PubMed ID: 6587015
    [Abstract] [Full Text] [Related]

  • 12. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses.
    Green DM, Brecher ML, Blumenson LE, Grossi M, Freeman AI.
    Cancer; 1982 Dec 15; 50(12):2722-7. PubMed ID: 6958351
    [Abstract] [Full Text] [Related]

  • 13. Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial.
    Willoughby ML.
    Br Med J; 1976 Apr 10; 1(6014):864-7. PubMed ID: 816410
    [Abstract] [Full Text] [Related]

  • 14. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P.
    Cancer; 1996 Apr 01; 77(7):1315-23. PubMed ID: 8608509
    [Abstract] [Full Text] [Related]

  • 15. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
    Haghbin M, Tan CT, Clarkson BD, Miké V, Burchenal JH, Murphy ML.
    Cancer Res; 1975 Mar 01; 35(3):807-11. PubMed ID: 1054287
    [Abstract] [Full Text] [Related]

  • 16. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
    Koizumi S, Fujimoto T, Takeda T, Yatabe M, Utsumi J, Mimaya J, Ninomiya T, Yanai M.
    Cancer; 1988 Apr 01; 61(7):1292-300. PubMed ID: 3278798
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychological study in patients with ALL. Two different CNS prevention therapies--cranial irradiation plus IT methotrexate vs. IT methotrexate alone.
    Pavlovsky S, Fisman N, Arizaga R, Castaño J, Chamoles N, Leiguarda R, Moreno R.
    Am J Pediatr Hematol Oncol; 1983 Apr 01; 5(1):79-86. PubMed ID: 6574715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
    Br Med J; 1975 Sep 06; 3(5983):563-6. PubMed ID: 1100179
    [Abstract] [Full Text] [Related]

  • 20. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B.
    J Clin Oncol; 1998 May 06; 16(5):1712-22. PubMed ID: 9586883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.